WT
BMY.RT

Whittier Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Whittier Trust’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-31,972
Closed -$22K – 1559
2020
Q4 		$22K Buy
31,972
+8,843
+38% +$18.8K ﹤0.01% 1032
2020
Q3 		$52K Buy
23,129
+7,326
+46% +$20.9K ﹤0.01% 822
2020
Q2 		$56K Sell
15,803
-27,425
-63% -$98.9K ﹤0.01% 773
2020
Q1 		$164K Sell
43,228
-15,408
-26% -$50.8K 0.01% 560
2019
Q4 		$176K Buy
+58,636
New +$152K ﹤0.01% 580

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Whittier Trust's BMY.RT Position: Q1 2021 in Review

Whittier Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 31,972 shares — an estimated $22K sold.

Whittier Trust first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $176K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Whittier Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Whittier Trust sold 31,972 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $22K.
  • Whittier Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Whittier Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $176K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Whittier Trust's 13F filing for Q1 2021, filed 26 Apr 2021.